Atlas Trials

A Phase IIII Study of AL8326 in Small Cell Lung Cancer

Clinical trial NCT06247605 · RECRUITING

Trial details

NCT number
NCT06247605
Sponsor
Advenchen Laboratories Nanjing Ltd.
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Small Cell Lung Carcinoma
Start date
2023-10-26
Primary completion
2028-07-01
Enrollment
243

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.